MARKER THERAPEUTICS, INC. Operating Lease, Weighted Average Discount Rate, Percent
MARKER THERAPEUTICS, INC. (MRKR) had Operating Lease, Weighted Average Discount Rate, Percent of 5.50% as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2023-05-15
- 2023-03-31: Operating Lease, Weighted Average Discount Rate, Percent 5.50%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 5.50%.
- 2022-09-30: Operating Lease, Weighted Average Discount Rate, Percent 5.50%.
- 2022-06-30: Operating Lease, Weighted Average Discount Rate, Percent 5.70%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2023-03-31 | 5.50% 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 5.50% 10-Q · filed 2023-05-15 | |
| 2022-09-30 | 5.50% 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 5.70% 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 5.70% 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 5.70% 10-K · filed 2023-03-22 | |
| 2021-09-30 | 5.70% 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 5.70% 10-Q · filed 2021-08-10 | |
| 2021-03-31 | 5.70% 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 5.70% 10-K · filed 2022-03-17 | |
| 2020-06-30 | 5.60% 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 6.80% 10-Q · filed 2021-05-12 | |
| 2019-12-31 | 6.80% 10-K · filed 2021-03-09 | |
| 2019-09-30 | 5.70% 10-Q · filed 2020-11-09 | 6.80% 10-Q · filed 2019-11-12 |
| 2019-06-30 | 6.80% 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 6.80% 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |